HOME › Press Releases › Fetal Monitoring Market worth $2.3 Billion by 2019
Fetal Monitoring Market worth $2.3 Billion by 2019
The report “Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the fetal monitoring market along with the estimates and forecasts of the revenue and market share analysis.
Browse 188 market data tables and 55 figures spread through 270 pages and in-depth TOC on “Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019"
Early buyers will receive 10% customization on reports.
The global fetal monitoring market is expected to reach $2,346.4 million by 2019 from $1,688.7 million in 2014, at a CAGR of 6.8% from 2014 to 2019.
The report segments this market based on products, portability, methods, applications, and end users. Among various end users, the hospitals segment is expected to account for the largest share of the market and is expected to grow at the highest CAGR from 2014 to 2019. The high growth in this segment can be attributed to the rising rate of maternal mortality and fetal birth defects, and increasing number of initiatives taken by government organizations for improving prenatal care.
Based on geography, the global fetal monitoring market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this geographic segment is driven by factors such as increasing government support for enhanced maternal facilities and rising company investments for the development of new products.
Key players in the fetal monitoring market include Analogic Corporation (U.S.), ArjoHuntleigh, Inc. (U.S.), Covidien PLC (U.S.), FUJIFILM SonoSite, Inc. (U.S.), GE Healthcare (U.K.), Natus Medical Incorporated (U.S.), Neoventa Medical (Sweden), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), and Spacelabs Healthcare Inc. (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252